Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1A | P07327 | 4/20 | 0.41 |
| ▸ | ADH1C | P00326 | 3/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 6/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | NAAA | Q02083 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | SHBG | P04278 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20774200 | 0.86 | NAAA (0.46) | EPHX1CYP1A2NAAAEPHX2 | |
| SCHEMBL1685454 | 0.83 | ADH1A (0.40) | ADH1AADH1CEPHX1ALDH1A1CYP1A2 | |
| SCHEMBL28334919 | 0.79 | ALDH1A1 (0.32) | EPHX1ALDH1A1 | |
| SCHEMBL27623363 | 0.76 | ADH1A (0.37) | ADH1AADH1CEPHX1ALDH1A1KDM4E | |
| SCHEMBL10863570 | 0.74 | ADH1A (0.38) | ADH1AADH1CEPHX1ALDH1A1KDM4E | |
| SCHEMBL9622547 | 0.73 | CTSK (0.35) | ADH1AADH1CALDH1A1 | |
| SCHEMBL231169 | 0.70 | ADH1A (0.36) | ADH1AADH1CEPHX1ALDH1A1KDM4E | |
| SCHEMBL27394443 | 0.70 | CYP1A2 (0.39) | ADH1AADH1CEPHX1CYP1A2NAAA | |
| SCHEMBL234676 | 0.70 | ADH1A (0.36) | ADH1AADH1CEPHX1ALDH1A1KDM4E | |
| SCHEMBL14219531 | 0.69 | ADH1A (0.39) | ADH1AADH1CALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4306566-B1 | CURABLE RESIN COMPOSITION, CURED PRODUCT AND ADHESIVE | ADEKA CORP (JP) | 2026-05-06 | — | — | EP | disclosed |
| US-12590178-B2 | Curable resin composition and method for suppressing curing shrinkage of curable resin composition | ADEKA CORPORATION (JP) | 2026-03-31 | — | — | US | disclosed |
| EP-4306567-B1 | CURABLE RESIN COMPOSITION, CURED PRODUCT, AND ADHESIVE | ADEKA CORP (JP) | 2025-06-04 | — | — | EP | disclosed |
| US-12269917-B2 | Curable resin composition | ADEKA CORPORATION (JP) | 2025-04-08 | — | — | US | disclosed |
| US-20250109324-A1 | CURING AGENT FOR EPOXY RESIN, AND ADHESIVE | SUNSTAR ENGINEERING INC. (JP) | 2025-04-03 | — | — | US | disclosed |
| US-20250109240-A1 | ONE-PACK TYPE EPOXY RESIN COMPOSITION | ADEKA CORPORATION (JP) | 2025-04-03 | — | — | US | disclosed |
| WO-2025062839-A1 | COMPOUND, EPOXY RESIN, CURABLE COMPOSITION, MATERIAL FOR RECYCLING, CURED ARTICLE, METHOD FOR PRODUCING CURED ARTICLE, METHOD FOR PRODUCING DECOMPOSITION PRODUCT, AND DECOMPOSITION METHOD | 株式会社ADEKA | 2025-03-27 | — | — | WO | disclosed |
| WO-2025047655-A1 | BLOCK URETHANE MATERIAL, COMPOSITION, CURED PRODUCT, METHOD FOR PRODUCING CURED PRODUCT, AND BLOCK URETHANE COMPOUND CONTAINED THEREIN | 株式会社ADEKA | 2025-03-06 | — | — | WO | disclosed |
| EP-4491653-A1 | ONE-PACK TYPE EPOXY RESIN COMPOSITION | ADEKA CORPORATION (JP) | 2025-01-15 | — | — | EP | disclosed |
| US-20250002707-A1 | CURABLE RESIN COMPOSITION, CURED PRODUCT, AND ADHESIVE | ADEKA CORPORATION (JP) | 2025-01-02 | — | — | US | disclosed |
| EP-3950761-A1 | CURABLE RESIN COMPOSITION | ADEKA CORPORATION (JP) | 2022-02-09 | — | — | EP | disclosed |
| CN-113544183-A | Curable resin composition | 株式会社艾迪科 | 2021-10-22 | — | — | CN | disclosed |
| WO-2021112104-A1 | RESIN COMPOSITION | 株式会社ADEKA | 2021-06-10 | — | — | WO | disclosed |
| WO-2021112091-A1 | RESIN COMPOSITION | 株式会社ADEKA | 2021-06-10 | — | — | WO | disclosed |
| WO-2021095534-A1 | CURABLE COMPOSITION, CURED OBJECT, FIBER-REINFORCED COMPOSITE MATERIAL, AND MOLDED ARTICLE AND PRODUCTION METHOD THEREFOR | DIC株式会社 | 2021-05-20 | — | — | WO | disclosed |
| WO-2021049390-A1 | CURABLE RESIN COMPOSITION | 株式会社ADEKA | 2021-03-18 | — | — | WO | disclosed |
| WO-2020196819-A1 | CURABLE RESIN COMPOSITION | 株式会社ADEKA | 2020-10-01 | — | — | WO | disclosed |
| CN-107001593-B | Thermosetting resin composition | 三键有限公司 | 2020-01-17 | — | — | CN | disclosed |
| US-8911586-B2 | One liquid type cyanate-epoxy composite resin composition | ADEKA CORPORATION (JP) | 2014-12-16 | — | — | US | disclosed |
| US-20110095453-A1 | ONE LIQUID TYPE CYANATE-EPOXY COMPOSITE RESIN COMPOSITION | ADEKA CORPORATION (JP) | 2011-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12590178-B2 | Curable resin composition and method for suppressing curing shrinkage of curable resin composition | SEM1, RER1, JMJD6 | ADH1A 2936/4885ADH1C 2844/4885EPHX1 1032/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.